Gut Health
4Allicin
7Berberine
1Borage Seed Oil
11Curcumin
- 0 Inflammatory Bowel Diseases.png
- 1 Inflammatory processes.png
- 2 Intestinal barrier function.png
- 3 Inflammatory Bowel Diseases.png
- 4 ulcerative colitis.png
- 5 Inflammatory Bowel Diseases.png
- 6 Ulcerative colitis.png
- 7 Inflammatory bowel disease.png
- 8 Inflammatory Bowel Diseases.png
- 9 Ulcerative colitis.png
- 10 Inflammatory bowel disease.png
17General
- 2005.09 - C. Mechanisms of Disease - The role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases.pdf
- 2011.01 - D. Zonulin and its regulation of intestinal barrier function - The biological door to inflammation, autoimmunity, and cancer.pdf
- 2011.03 - E. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer.pdf
- 2012.02 - A. The gut microbiota in 2011 - Translating the microbiota to medicine.pdf
- 2012.07 - P. Comparison with ancestral diets and inflammatory microbiota copie.pdf
- 2012.10 - F. Intestinal Permeability and its regulation by zonulin.pdf
- 2015.04 - O. Roles and Regulation of the Mucus Barrier in the Gut.pdf
- 2015.07 - I. The gut microbiota and inflammatory bowel disease.pdf
- 2015.09 - B. Gut microbiota - A key player in health and disease.pdf
- 2016.08 - L. Alzheimer's disease and gut microbiota copie.pdf
- 2017.01 - K. The gut-brain axis in Parkinson's disease pathogenesis.pdf
- 2017.03 - N. Oral Samples as Non-Invasive Proxies for Assessing the Rumen Microbial Community.pdf
- 2017.05 - G. Leaky Gut As a Danger Signal for Autoimmune Diseases.pdf
- 2017.06 - H. Fungal dysbiosis - Immunity and interactions at mucosal barriers.pdf
- 2017.10 - M. The Mouth Is Salivating to Tell Us Something.pdf
- 2017.11 - J. Enhanced understanding of the microbiome is helping medicine.pdf
- 2018.01 - P**. The role of the gut microbiome in systemic inflammatory disease.pdf
4Grapefruit Seed
- 2008.07 - A. Grapefruit juice and its furocoumarins inhibits autoinducer signaling and biofilm formation in bacteria.pdf
- 2010.06 - B. Grapefruit bioactive limonoids modulate E. coli O157-H7 TTSS and biofilm.pdf
- 2016.05 - C. Natural Therapeutic Options in Endodontics - A Review.pdf
- 2016.12 - D. Effects of malic acid or|and grapefruit seed extract for the inactivation of common food pathogens on fresh-cut lettuce.pdf
4Gut-Brain Axis
- 2014.11 - A. Gut Microbes and the Brain - Paradigm Shift in Neuroscience.pdf
- 2016.09 - B. The bowel and beyond - The enteric nervous system in neurological disorders.pdf
- 2017.08 - C. Extracellular Vesicles in Brain Tumours and Neurodegenerative Diseases.pdf
- 2017.12 - D. Neuromicrobiology - How Microbes Influence the Brain.pdf
12IBS-IBD
- 2013.03 - A. Modulation of intestinal barrier by intestinal microbiota - Pathological and therapeutic implications.pdf
- 2013.05 - B. Intestinal microbiota and its role in irritable bowel syndrome (IBS).pdf
- 2014.02 - E. The overlap between IBS and IBD - what is it and what does it mean?.pdf
- 2014.02 - The overlap between IBS and IBD - what is it and what does it mean?.pdf
- 2014.08 - C. A role for the gut microbiota in IBS.pdf
- 2014.10 - G.Irritable bowel syndrome - a microbiome-gut-brain axis disorder?.pdf
- 2014.10 - Irritable bowel syndrome - a microbiome-gut-brain axis disorder?.pdf
- 2015.01 - D. Crosstalk at the mucosal border - Importance of the gut microenvironment in IBS.pdf
- 2016.01 - I. Review article - The potential mechanisms of action of rifaximin in the management of inflammatory bowel diseases.pdf
- 2016.09 - 2016.09 - IBS and IBD - separate entities or on a spectrum? - abstract.png
- 2016.09 - F. IBS and IBD - separate entities or on a spectrum?.pdf
- 2017.03 - H. The Microbiome-Gut-Brain Axis in Health and Disease.pdf
7Intestinal Dysbiosis
2L-Glutamine
8Low igA
- 2011.04 - A. Immunoglobulin responses at the mucosal interface.pdf
- 2012.01 - B. The Microbiome in Infectious Disease and Inflammation.pdf
- 2013.12 - C. Nonredundant function of soluble LTα3 produced by innate lymphoid cells in intestinal homeostasis.pdf
- 2014.02 - D. IgA deficiency and autoimmunity.pdf
- 2015.09 - E. BALB-c and C57BL-6 Mice Differ in Polyreactive IgA Abundance, which Impacts the Generation of Antigen-Specific IgA and Microbiota Diversity.pdf
- 2015.11 - F. Autoimmunity and Immunodeficiency.pdf
- 2016.06 - H. Helicobacter pylori infection in patients with selective immunoglobulin a deficiency.pdf
- 2016.11 - G. The epithelial barrier and immunoglobulin A system in allergy.pdf
8LPS-Binding Protein
- 2012.03 - G. Endotoxin increase after fat overload is related to postprandial hypertriglyceridemia in morbidly obese patients.pdf
- 2012.05 - A. LPS-binding protein enables intestinal epithelialrestitution despite LPS exposure.pdf
- 2013.01 - B. Determinants of Serum Concentrations of Lipopolysaccharide-Binding Protein (LBP) in the Adult Population - The Role of Obesity.pdf
- 2013.02 - C. Porphyromonas gingivalis LPS stimulates the expression of LPS-binding protein in human oral keratinocytes in vitro.pdf
- 2016.04 - D. Lipopolysaccharide-binding protein is bound and internalized by host cells and colocalizes with LPS in the cytoplasm - Implications for a role of LBP in intracellular LPS-signaling.pdf
- 2017.02 - H. LPS Induces Hyper-Permeability of Intestinal Epithelial Cells.pdf
- 2018.05 - E. The level of lipopolysaccharide-binding protein is elevated in adult patients with obstructive sleep apnea.pdf
- 2018.06 - F. Association of gut microbial communities with plasma lipopolysaccharide-binding protein (LBP) in premenopausal women.pdf
5Migrating Motor Complex
- 2012.03 - A. The migrating motor complex- control mechanisms and its role in health and disease.pdf
- 2014.03 - B. Interdigestive migrating motor complex - Its mechanism and clinical importance.pdf
- 2016.02 - C. Redefining the functional roles of the gastrointestinal migrating motor complex and motilin in small bacterial overgrowth and hunger signaling.pdf
- 2017.01 - D. Underlying mechanism of the cyclic migrating motor complex in Suncus murinus - a change in gastrointestinal pH is the key regulator.pdf
- 2017.06 - E. Importance of the enteric nervous system in the control of the migrating motility complex.pdf
5Myeloperoxidase
- 2016.01 - A. Neutrophil-Mediated Regulation of Innate and Adaptive Immunity - The Role of Myeloperoxidase.pdf
- 2017.12 - B. Myeloperoxidase Deficiency.pdf
- 2018.02 - C. Myeloperoxidase - Its role for host defense, inflammation, and neutrophil function.pdf
- 2018.04 - D. Myeloperoxidase as an Active Disease Biomarker - Recent Biochemical and Pathological Perspectives.pdf
- 2018.05 - E. Myeloperoxidase in the inflamed colon - A novel target for treating inflammatory bowel disease.pdf
3Obesity
1Organo Oil
1Prebiotics
12Probiotics
- 0 Immunomodulation.png
- 1 Ulcerative colitis.png
- 2 Immunomodulation.png
- 3 Ulcerative colitis-psychological stress.png
- 4 Ulcerative colitis-intestinal barrier.png
- 5 Ulcerative colitis.png
- 6 Immunomodulation.png
- 7 Immunomodulation.png
- 8 Ulcerative colitis.png
- 9 Immunomodulation.png
- 10 Inflammatory bowel disease-intestinal barrier.png
- 11 Immunomodulation.png
2Psyllium Seed Husk
5Saccharomyces boulardii
11Thyroid
- 1988.01 - A. Thyroid hormone and the gut.pdf
- 1988.02 - B. Hydrolysis of iodothyronine conjugates by intestinal bacteria.pdf
- 1995.04 - C. Endotoxin injection was associated with decreases in T4 , free T4 , T3 , and TSH and a rise in rT3.pdf
- 2004.01 - D. Ultrastructural changes in enterocytes in subjects with Hashimoto’s thyroiditis.pdf
- 2005.08 - E. Alternate Pathways of Thyroid Hormone Metabolism.pdf
- 2007.12 - F. Structural and functional alterations in thyroid gland as elements of chronic endotoxicosis.pdf
- 2010.09 - J. Enterohepatic Recirculation of Thyroid Hormones.pdf
- 2014.11 - G. Gut microbe analysis between hyperthyroid and healthy individuals.pdf
- 2015.08 - H. Does microbiota composition affect thyroid homeostasis?.pdf
- 2015.08 - H. Does microbiota composition affect thyroid homeostasis?.pdf
- 2017.03 - K. Environmental Issues in Thyroid Diseases.pdf
6Zonuline
- 2016.10 - A. Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases.pdf
- 2017.04 - B. Increased intestinal permeability, measured by serum zonulin, is associated with metabolic risk markers in overweight pregnant women.pdf
- 2017.07 - C. Evaluation of circulating zonulin as a potential marker in the pathogenesis of nonalcoholic fatty liver disease.pdf
- 2017.09 - D. Increased Serum Zonulin Levels as an Intestinal Permeability Marker in Autistic Subjects.pdf
- 2017.09 - E. Intestinal Permeability Biomarker Zonulin is Elevated in Healthy Aging.pdf
- 2018.04 - F. Serum Zonulin and Endotoxin Levels in Exceptional Longevity versus Precocious Myocardial Infarction.pdf
Thyroid Hormones
5Cholesterol & Lipids
- 1985.05 - A. Cholesterol & Lipids.pptx
- 2008.04 - B. Thyrotropin levels and risk of fatal coronary heart disease - The HUNT study.pdf
- 2010.05 - E. A high normal TSH is associated with the metabolic syndrome.pdf
- 2014.06 - C. Dyslipidemias and hypothyroidism.pdf
- 2014.12 - D. Subclinical Hypothyroidism - Summary of Evidence.pdf
4Fatigue
1Gluten - Thyroid
8Guidelines
4Gut Health
- 2002.03 - C. Increased colonic intraepithelial lymphocytes in patients with Hashimoto's thyroiditis.pdf
- 2002.09 - A. Effect of thyroid hormones on stress ulcer formation.pdf
- 2010.02 - D. Thyroid Disorders and Inflammatory Bowel Disease.pdf
- 2014.05 - B. Link between hypothyroidism and small intestinal bacterial overgrowth.pdf
7Immune System
- 1995.07 - A. Thyroid involvement in patients with active inflammatory bowel diseases.pdf
- 1996.02 - B. Hormone regulation of murine T cells - Potent tissue-specific immunosuppressive effects of thyroxine targeted to gut T cells.pdf
- 2003.06 - C. The human neuroendocrine thyrotropin-releasing hormone receptor promoter is activated by the haematopoietic transcription factor c-Myb.pdf
- 2006.03 - D. The Immune System as a Regulator of Thyroid Hormone Activity.pdf
- 2011.01 - E. Immunological regulation of metabolism - A novel quintessential role for the immune system in health and disease.pdf
- 2013.08 - F. Hypothalamic neurohormones and immune responses.pdf
- 2014.04 - G. Biological Impact of the TSHβ Splice Variant in Health and Disease.pdf
3Liver
3Metabolism
4NDT Treatment
- 2015.10 - A. HISTORICAL AND CURRENT PERSPECTIVE IN THE USE OF THYROID EXTRACTS FOR THE TREATMENT OF HYPOTHYROIDISM.pdf
- 2015.10 - B. A MUCH-NEEDED HISTORIC PERSPECTIVE ON THE THERAPEUTIC USE OF THYROID HORMONES.pdf
- 2017.05 - C. ADVERSE EVENT REPORTING IN PATIENTS TREATED WITH THYROID HORMONE EXTRACT.pdf
- 2018.02 - D. LETTER TO THE EDITOR.pdf
7New Approach
- 1999.02 - B. Usefulness of T3 Treatments - articles edited.pdf
- 2015.10 - D. Historical and Current Perspective in the Use of Thyroid Extracts for the Treatment of Hypothyroidism.pdf
- 2015.10 - E. A Much-needed Historic Perspective on the Therapeutic Use of Thyroid Hormones.pdf
- 2016.05 - A. Clinical Challenges in Thyroid Disease - Time for a New Approach.pdf
- 2017.05 - F. Adverse Event Reporting in Patients Treated with Thyroid Hormone Extract.pdf
- 2018.01 - C. Management of hypothyroidism with combination thyroxine (T4) and triiodothyronine (T3) hormone replacement in clinical practice - A review of suggested guidance.pdf
- 2018.02 - G. Letter to the Editor.pdf
5Surrogate Markers
- 1993.01 - A. Conversion of beta-carotene to vitamin A.pdf
- 1994.08 - D. Conversion of beta-carotene to vitamin A - bundle edited.ppt
- 2005.11 - B. Cell type-specific expression of beta-carotene 9',10'-monooxygenase in human tissues.pdf
- 2009.06 - Growth hormone - insulin-like growth factor axis in patients with subclinical thyroid dysfunction - png edied.pdf
- 2015.06 - C. A genetic dissection of intestinal fat-soluble vitamin and carotenoid absorption.pdf
1T3 Treatment Safety
1Treatment for AITD
4TSH Range
- 1995.07 - A. TSH Range - articles edited.pdf
- 1995.07 - A. TSH Range.pptx
- 1996.08 - C. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism.pdf
- 2013.09 - B. A review of the clinical consequences of variation in thyroid function within the reference range.pdf
6Ultrasonography
- 2013.01 - B. Somatotypological and regional regularities of ultrasound anatomy of the thyroid gland.pdf
- 2013.03 - A. Thyroid ultrasound.pdf
- 2013.03 - A. Thyroid ultrasound.pdf
- C. The association between hypoechogenicity or irregular echo pattern at thyroid ultrasonography and thyroid function in the general population.pdf
- C. The association between hypoechogenicity or irregular echo pattern at thyroid ultrasonography and thyroid function in the general population.pdf
- D. Medscape - Hashimoto Thyroiditis.html
Pregnenolone
1Compounding
1Inflammatory Bowel Diseases
3Leaky Gut
- 1999.01 - A. The PPARs and PXRs - Nuclear xenobiotic receptors that define novel hormone signaling pathways.pdf
- 2014.05 - B. Pregnane X receptor agonists enhance intestinal epithelial wound healing and repair of the intestinal barrier following the induction of experimental colitis.pdf
- 2016.10 - C. Pregnane X Receptor Activation Attenuates Inflammation-Associated Intestinal Epithelial Barrier Dysfunction.pdf
5Miscellaneous
- 2011.09 - A. Pregnenolone as a novel therapeutic candidate in schizophrenia.pdf
- 2016.06 - B. Neurosteroids and potential therapeutics - Focus on pregnenolone.pdf
- 2016.07 - C. Nongenomic actions of neurosteroid pregnenolone and its metabolites.pdf
- 2020.05 - Allopregnanolone, the Neuromodulator Turned Therapeutic Agent.pdf
- 2021.06 - Revisiting steroidogenesis and its role in immune regulation with the advanced tools and technologies.pdf
5Tolerance & Safety
- 2009.07 - A. Well tolerated - 500 mg per day -- Proof-of-concept trial with the neurosteroid pregnenolone targeting cognitive and negative symptoms in schizophrenia.pdf
- 2010.07 - B. Well tolerated - 100 mg per day - safe -- Pregnenolone for cognition and mood in dual diagnosis patients.pdf
- 2010.10 - C. Well tolerated - 30 mg & 200 mg per day -- Pregnenolone and dehydroepiandrosterone as an adjunctive treatment in schizophrenia and schizoaffective disorder.pdf
- 2014.09 - D. Well tolerated - 500 mg per day -- Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia.pdf
- 2014.11 - E. Well tolerated - 500 mg per day - can be safely adinistered -- A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression.pdf
Herbs
6Allicin
- 2014.08 - A. Allicin Chemistry and Biological Properties.pdf
- 2016.11 - B. Effects of Allicin on Hypertension and Cardiac Function in Chronic Kidney Disease.pdf
- 2017.08 - C. Allicin improves carotid artery intima-media thickness in coronary artery disease patients with hyperhomocysteinemia.pdf
- 2017.09 - D. The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan.pdf
- 2017.11 - E. Neuroprotective effects of allicin on ischemia-reperfusion brain injury.pdf
- 2018.04 - F. Allicin activates autophagic cell death to alleviate the malignant development of thyroid cancer.pdf
4AMPK Activators
- 2014.07 - A. AMPK at the Nexus of Energetics and Aging.pdf
- 2016.04 - B. AMPK activators - Mechanisms of action and physiological activities.pdf
- 2017.11 - C. Strawberry consumption improves aging-associated impairments,mitochondrial biogenesis and functionality through the AMP-activatedprotein kinase signaling cascade.pdf
- 2018.11 - D. Structure and Physiological Regulation of AMPK.pdf
4Anthocyanins
- 2007.11 - A. Anthocyanins induce the activation of phase II enzymes through the antioxidant response element pathway against oxidative stress-induced apoptosis.pdf
- 2017.08 - B. Anthocyanidins and anthocyanins - Colored pigments as food, pharmaceutical ingredients, and the potential health benefits.pdf
- 2017.10 - C. Dietary Anthocyanins and Insulin Resistance - When Food Becomes a Medicine.pdf
- 2017.10 - D. Dietary Anthocyanins against Obesity and Inflammation.pdf
7Apigenin
- 2010.11 - G. Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition.pdf
- 2017.10 - A. Plant flavone apigenin - An emerging anticancer agent.pdf
- 2018.07 - F. Apigenin Retards Atherogenesis by Promoting ABCA1-Mediated Cholesterol Efflux and Suppressing Inflammation.pdf
- 2018.09 - B. Apigenin prevents metabolic syndrome in high-fructose diet-fed mice by Keap1-Nrf2 pathway.pdf
- 2019.03 - C. The Therapeutic Potential of Apigenin.pdf
- 2019.04 - D. A Comprehensive Assessment of Apigenin as an Antiproliferative, Proapoptotic, Antiangiogenic and ImmunomodulatoryPhytocompound.pdf
- 2019.04 - E. The natural plant flavonoid apigenin is a strong antioxidant that effectively delays peripheral neurodegenerativeprocesses.pdf
11Ashwagandha
- 1 Anti-inflammatory.png
- 2 Immunomodulation.png
- 3 Immunomodulation.png
- 4 Immunomodulation.png
- 5 Inflammatory Bowel Disease.png
- 2014.06 - A. Effects of Ashwagandha (roots of Withania somnifera) on neurodegenerative diseases.pdf
- 2014.12 - B. An alternative treatment for anxiety - A systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera).pdf
- 2017.01 - C. Body Weight Management in Adults Under Chronic Stress Through Treatment With Ashwagandha Root Extract - A Double-Blind, Randomized, Placebo-Controlled Trial.pdf
- 2017.11 - D. Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions.pdf
- 2018.03 - E. Role of Withania somnifera (Ashwagandha) in the management of male infertility.pdf
- 2018.03 - F. Efficacy and Safety of Ashwagandha Root Extract in Subclinical Hypothyroid Patients - A Double-Blind, Randomized Placebo-Controlled Trial.pdf
5Baicalin
- 2015.10 - A. The effects of baicalein and baicalin on mitochondrial function and dynamics - A review.pdf
- 2017.05 - B. The Effects of Baicalin and Baicalein on CerebralIschemia - A Review.pdf
- 2017.12 - C. The Effects of Baicalin and Baicalein on CerebralIschemia - A Review.pdf
- 2018.06 - D. Neuroprotective and Cognitive Enhancement Potentials of Baicalin - A Review.pdf
- 2020.02 - E. Baicalin and its aglycone - A novel approach for treatment of metabolic disorders.pdf
23Berberine
- 2011.08 - Repeated administration of berberine inhibits cytochromes P450 in humans.pdf
- 2016.06 - M. Berberine activates Nrf2 nuclear translocation and inhibits apoptosis induced by high glucose in renal tubular epithelial cells.pdf
- 2017.06 - C. Berberine regulates type 2 diabetes mellitus related with insulin resistance.pdf
- 2017.06 - Q. Regulation of PCSK9 by nutraceuticals.pdf
- 2017.09 - A. Metformin and berberine, two versatile drugs in treatment of common metabolic diseases.pdf
- 2018.01 - B. Effectiveness and safety of bifidobacteria and berberine in people with hyperglycemia - Study protocol for a randomized controlled trial.pdf
- 2018.01 - F. Berberine treatment increases Akkermansia in the gut and improves high-fat diet-induced atherosclerosis in Apoe--mice.pdf
- 2018.07 - D. The Pathogenesis of Diabetes Mellitus by Oxidative Stress and Inflammation - Its Inhibition by Berberine.pdf
- 2018.07 - I. Update on the Benefits and Mechanisms of Action of the Bioactive Vegetal Alkaloid Berberine on Lipid Metabolism and Homeostasis.pdf
- 2018.07 - J. Berberine Improves Benign Prostatic Hyperplasia via Suppression of 5 Alpha Reductase and Extracellular Signal-Regulated Kinase in Vivo and in Vitro.pdf
- 2018.09 - E. The Effects of Berberine on the Gut Microbiota inApc Mice Fed with a High Fat Diet.pdf
- 2018.09 - G. Berberine Exerts a Protective Effect on Gut-Vascular Barrier via the Modulation of the Wnt.Beta-Catenin SignalingPathway During Sepsis.pdf
- 2018.11 - H. Effects of berberine on blood glucose in patientswith type 2 diabetes mellitus - A systematic literature review and a meta-analysis.pdf
- 2018.11 - K. Berberine is a potential therapeutic agent for metabolic syndrome via brown adipose tissue activation and metabolism regulation.pdf
- 2018.11 - L. Effects of berberine on tumor growth and intestinal permeability in HCT116 tumor-bearing mice using polyamines astargets.pdf
- 2019.03 - N. Berberine alleviates nonalcoholic fatty liver induced by a high-fat diet in mice by activating SIRT3.pdf
- 2019.03 - O. Berberine and musculoskeletal disorders - The therapeutic potential and underlying molecular mechanisms.pdf
- 2019.03 - P. Berberine attenuates hepatic oxidative stress in rats with non-alcoholic fatty liver disease via the Nrf2-ARE signalling pathway.pdf
- 2021.04 - Berberine, a potential prebiotic to indirectly promote Akkermansia growth through stimulating gut mucin secretion.pdf
- 2023.02 - The Role of Phytochemicals and Gut Microbiome in Atherosclerosis in Preclinical Mouse Models.pdf
- 2023.06 - A Comprehensive Insight into the Effect of Berberine on Nonalcoholic Fatty Liver Disease (NAFLD) - A Systematic Review.pdf
- 2023.11 - Addressing the preventive and therapeutic perspective of berberine against diabetes.pdf
- 2024.07 - A deep learning-driven discovery of berberine derivatives as novel antibacterial against multidrug-resistant Helicobacter pylori.pdf
4Cocoa
- 2009.03 - A. Flavanols, the Kuna, Cocoa Consumption, and Nitric Oxide.pdf
- 2015.08 - B. Cocoa Flavanol Cardiovascular Effects Beyond Blood Pressure Reduction.pdf
- 2016.01 - C. Preventive Effects of Cocoa and Cocoa Antioxidants.pdf
- 2017.06 - D. Cocoa and Dark Chocolate Polyphenols From Biologyto Clinical Applications.pdf
5Coffee
- 2016.04 - A. Effects of coffee-caffeine on brain health and disease - What should I tell my patients.pdf
- 2017.05 - B. Coffee - The Magical Bean for Liver Diseases.pdf
- 2017.11 - C. Coffee consumption and health - Umbrella review of meta-analyses of multiple health outcomes.pdf
- 2018.05 - D. Coffee for cardioprotection and longevity.pdf
- 2018.06 - E. Coffee consumption and reduced risk of developingtype 2 diabetes - A systematic review with meta-analysis.pdf
5Curcumin
- 2018.05 - A. Use of Curcumin, a Natural Polyphenol for Targeting Molecular Pathways in Treating Age-Related Neurodegenerative Diseases.pdf
- 2018.05 - B. Curcumin, A Polyphenolic Curcuminoid With Its Protective Effects and Molecular Mechanisms in Diabetes and Diabetic Cardiomyopathy.pdf
- 2018.06 - C. The Role of Curcumin in Prevention and Management of Metastatic Disease.pdf
- 2018.07 - D. Curcumin in Liver Diseases - A Systematic Review of the Cellular Mechanisms of Oxidative Stress and Clinical Perspective.pdf
- 2018.08 - E. Evidence of curcumin and curcumin analogue effects in skin diseases - A narrative review.pdf
2Cyanidin
5Food Antioxidants
- 2007.11 - A. Anthocyanins induce the activation of phase II enzymes through the antioxidant response element pathway against oxidative stress-induced apoptosis.pdf
- 2015.06 - B. Modulation of Metabolic Detoxification Pathways Using Foods and Food-Derived Components.pdf
- 2017.01 - E. Multifunctions of dietary polyphenols in the regulation of intestinal inflammation.pdf
- 2017.10 - C. Molecular Mechanisms and Pathways as Targets for Cancer Prevention and Progression with Dietary Compounds.pdf
- 2018.12 - D. Protective Role of Polyphenols against Vascular Inflammation, Aging and Cardiovascular Disease.pdf
4Ginger
- 2006.02 - A. Species differences in the prokinetic effects of ginger.pdf
- 2017.12 - B. Plants of the Genus Zingiber as a Source of Bioactive Phytochemicals - From Tradition to Pharmacy.pdf
- 2019.03 - C. Dietary ginger as a traditional therapy for bloodsugar control in patients with type 2 diabetes mellitus.pdf
- 2019.05 - D. Bioactive Compounds and Bioactivities of Ginger (Zingiber officinale Roscoe).pdf
7Guggul
- 1999.01 - A. Gugulu (Commiphora mukul) induces triiodothyronine production - Possible involvement of lipid peroxidation.pdf
- 2005.01 - B. Guggulu (Commiphora mukul) potentially ameliorates hypothyroidism in female mice.pdf
- 2007.12 - C. Therapeutic Effects of Guggul and Its Constituent Guggulsterone - Cardiovascular Benefit.pdf
- 2014.09 - D. The appetite regulatory effect of guggulsterones in rats - A repertoire of plasma hormones and neurotransmitters.pdf
- 2016.01 - E. Guggulsterone and Its Role in Chronic Diseases.pdf
- 2016.01 - F. Guggulsterone for Chemoprevention of Cancer.pdf
- 2017.06 - G. Beneficiary effect of Commiphora mukul ethanolic extract against high fructose diet induced abnormalities in carbohydrate and lipid metabolism in wistar rats.pdf
4Maca
- 2010.08 - A. Maca (L. meyenii) for improving sexual function -A systematic review.pdf
- 2014.01 - B. Maca (Lepidium meyenii Walp), a review of its biological properties.pdf
- 2018.12 - C. Research and application progress of Lepidium meyenii (maca).pdf
- 2018.12 - D. Progress on the Chemical Constituents Derived from Glucosinolates in Maca (Lepidium meyenii).pdf
7Magnolia | Honokiol
- 2006.06 - A. Overview of the Pharmacological Features of Honokiol.pdf
- 2010.09 - B. Honokiol and magnolol as multifunctional antioxidative molecules for dermatologic disorders.pdf
- 2012.12 - C. Honokiol - A novel natural agent for cancer prevention and therapy.pdf
- 2015.04 - D. Honokiol blocks and reverses cardiac hypertrophy in mice by activating mitochondrial SIRT3.pdf
- 2016.12 - G. Magnolia officinalis (Hou Po) bark extract stimulates the Nrf2-pathway in hepatocytes and protects against oxidative stress.pdf
- 2017.11 - E. Neuroprotective effects of honokiol - From chemistry to medicine.pdf
- 2018.11 - F. Honokiol - An anticancer lignan.pdf
7NRF2 Factor
- 2012.03 - E. Nrf2 Protein Up-regulates Antiapoptotic Protein Bcl-2 and Prevents Cellular Apoptosis.pdf
- 2015.02 - A. Nrf2, a master regulator of detoxification and also antioxidant, anti-inflammatort and other cytoprotective mechanisms, is raised by health promoting factors.pdf
- 2016.01 - B. Sulforaphane and Other Nutrigenomic Nrf2 Activators - Can the clinician's expectation be matched by the reality.pdf
- 2016.08 - C. Multiple regulations of Keap1-Nrf2 system by dietary phytochemicals.pdf
- 2016.12 - F. Magnolia officinalis (Hou Po) bark extract stimulates the Nrf2-pathway in hepatocytes and protects against oxidative stress.pdf
- 2018.01 - D. The role of Nrf2 signaling in counteracting neurodegenerative diseases.pdf
- 2019.05 - G. Ginkgo biloba extract protects human melanocytes from H2 O2 -induced oxidative stress by activating Nrf2.pdf
10Quercetin
- 2016.07 - A. Overviews of Biological Importance of Quercetin - A Bioactive Flavonoid.pdf
- 2017.02 - B. Quercetin Inhibits LPS-Induced Inflammation and ox-LDL-Induced Lipid Deposition.pdf
- 2018.01 - C. Safety Aspects of the Use of Quercetin as a Dietary Supplement.pdf
- 2018.07 - D. Therapeutic potential of quercetin as a cardiovascular agent.pdf
- 2018.07 - E. Anticancer potential of quercetin - A comprehensive review.pdf
- 2018.09 - F. Quercetin in Food - Possible Mechanisms of Its Effect on Memory.pdf
- 2018.10 - G. Effect of quercetin on the echocardiographic parameters of left ventricular diastolic function in patients with gout and essential hypertension.pdf
- 2018.12 - H. Pharmacological Effect of Quercetin in Hypertension and Its Potential Application in Pregnancy-Induced Hypertension.pdf
- 2019.12 - J. Characteristics of flavonoids as potent MERSâ€CoV 3Câ€like protease inhibitors.pdf
- 2020.02 - I. Randomised clinical trial to determine the safetyof quercetin supplementation in patients with chronic obstructive pulmonary disease.pdf
3Resveratrol
9Rhodiola
- 1 Antioxidant.png
- 2 Anti-inflammatory.png
- 3 Antioxidant - Anti-inflammatory.png
- 4 Antioxidant - Immunomodulatory.png
- 2015.12 - A. The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms.pdf
- 2017.02 - B. Rhodiola rosea in Subjects with Prolonged or Chronic Fatigue Symptoms - Results of an Open-Label Clinical Trial.pdf
- 2018.01 - C. Stress management and the role of Rhodiola rosea - A Review.pdf
- 2018.05 - D. Antioxidant and hepatoprotective effects of purified Rhodiola rosea polysaccharides.pdf
- 2018.07 - E. Antioxidant and Antibacterial Activity of Roseroot (Rhodiola rosea L.) Dry Extracts.pdf
5Sulforaphane
- 2014.09 - A. Sulforaphane treatment of autism spectrum.pdf
- 2017.02 - B. KEAP1 and done Targeting the NRF2 pathway with sulforaphane.pdf
- 2017.06 - C. Sulforaphane reduces hepatic glucose production and improves glucose control in patients with type 2 diabetes.pdf
- 2017.07 - D. The role of Sulforaphane in cancer chemoprevention and health.pdf
- 2017.10 - E. Sulforaphane from Broccoli Reduces Symptoms of Autism - A Follow-up Case Series from a Randomized Double-blind Study.pdf
3Tea
6Tribulus
- 2005.01 - A. Saponins in Tribulus terrestris – Chemistry and Bioactivity.pdf
- 2014.12 - B. Clinical Assessment of Tribulus terrestris Extract in the Treatment of Female Sexual Dysfunction.pdf
- 2016.05 - C. Pilot Study on the Effect of Botanical Medicine (Tribulus terrestris) on Serum Testosterone Level and Erectile Function in Aging Males With Partial Androgen Deficiency (PADAM).pdf
- 2016.06 - D. Effects of Tribulus terrestris saponins on exercise performance in overtraining rats and the underlying mechanisms.pdf
- 2017.06 - E. Effect of oral administration of Tribulus terrestris extract on semen quality and body fat index of infertile men.pdf
- 2018.05 - F. Efficacy of Tribulus Terrestris for the treatment of premenopausal women with hypoactive sexual desire disorder - A randomized double-blinded, placebo-controlled trial.pdf
Allergology
11Evolution of Medicine
- A. Choosing Wisely in the UK - The Academy of Medical Royal Colleges’ initiative to reduce the harms of too much medicine.pdf
- B. Making Better Use of Research Findings.pdf
- C. Two Reasons Conventional Medicine Will Never Solve Chronic Disease.html
- D. DeÌclaration d'Helsinski.pdf
- E. WMA Declaration of Helsinki – Ethical Principles for Medical Research Involving Human Subjects – WMA – The World Medical Association.html
- F. Definition of Health according WHO (1946).pdf
- G. GMC - Good Medical Practice 2017.pdf
- H. Research and Evidence-Based Practice - Delmar Learning.pdf
- I. Implementing Guidelines in General Practice Care 1992.pdf
- J. Prof Richard GROL - University of Nijmegen.pdf
- K. TED Talk Dr Rangan CHATTERJEE.pdf
10Oxalates
- 2002.08 - Oxalobacter formigenes and Its Potential Role in Human Health.pdf
- 2004.01 - A. Oxalobacter formigenes and its role in oxalate metabolism in the human gut°.pdf
- 2010.07 - D. Calcium Oxalate Stone Formation in the Inner Ear°.pdf
- 2011.04 - B. Factors Related to Colonization with Oxalobacter formigenes°.pdf
- 2016.12 - C. The role of the microbiome in kidney stone formation°.pdf
- 2019.03 - Dietary oxalate and kidney stone formation.pdf
- 2020.03 - Risk of Kidney Stones - Influence of Dietary Factors, Dietary Patterns, and Vegetarian–Vegan Diets.pdf
- 2021.06 - Nutrition and Kidney Stone Disease.pdf
- 2023.02 - Oxalate homeostasis.pdf
- 2023.08 - Oxalate in Foods - Extraction Conditions, Analytical Methods, Occurrence, and Health Implications.pdf
Neurology / Sleep
1Brain Microbiota
5GABA
- 2002.05 - A. GABA mechanisms and sleep.pdf
- 2015.01 - B. The Improvement of Sleep by Oral Intake of GABA and Apocynum venetum Leaf Extract.pdf
- 2015.10 - C. A study on quality components and sleep-promoting effects of GABA black tea.pdf
- 2016.09 - D. Sleep-promoting effects of the GABA--5-HTP mixture in vertebrate models.pdf
- 2018.07 - E. Safety and Efficacy of Gamma-Aminobutyric Acid from Fermented Rice Germ in Patients with Insomnia Symptoms - A Randomized, Double-Blind Trial.pdf
7L-Theanine
- 2016.01 - Anti-Stress, Behavioural and Magnetoencephalography Effects of an L-Theanine-Based Nutrient Drink.pdf
- 2017.05 - A. L-theanine, unique amino acid of tea and its metabolism, health effects, and safety.pdf
- 2018.03 - B. L-Theanine - An astounding sui generis integrant in tea.pdf
- 2022.01 - An Exploratory Evaluation of a Low Dose Theanine Consumption on Improving Sleep in Middle-Aged and Older Males.pdf
- 2022.04 - A Novel Theanine Complex, Mg-L-Theanine Improves Sleep Quality via Regulating Brain Electrochemical Activity.pdf
- 2022.04 - L-Theanine - A Unique Functional Amino Acid in Tea (Camellia sinensis L.) With Multiple Health Benefits and Food Applications.pdf
- 2024.08 - Safety and Efficacy of AlphaWave® l-Theanine Supplementation for 28 Days in Healthy Adults with Moderate Stress.pdf
3Melatonin
3Neuromicrobiology
Hepatology
5Gamma-GT
- 2000.05 - A. Coffee consumption and decreased serum gamma-glutamyltransferase a study of middle-aged Japanese men.pdf
- 2012.04 - B. Gamma-glutamyl transferase risk and prognosis of cancer.pdf
- 2013.01 - E. Comparative Levels of ALT, AST, ALP and GGT in Liver associated Diseases.pdf
- 2015.10 - C. Gamma-Glutamyltransferase A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk.pdf
- 2018.01 - D. Gamma-glutamyl transferase and the risk of atherosclerosis and coronary heart disease.pdf
3Liver Detoxification
Sexual Hormones
32-16a-OH-ΠRatio
- 2002.04 - A. Estrogen Metabolism and The Diet-Cancer Connection - Rationale for assessing the ratio of urinary hydroxylated estrogen metabolites.pdf
- 2006.01 - B. Measuring Urinary Estrogen Metabolites for Cancer Risk Assessment.pdf
- 2015.02 - C. Epidemiologic studies of estrogen metabolism and breast cancer.pdf
5Calcium-D-Glucarate
- 1990.10 - A. Potential use of D-glucaric acid derivatives in cancer prevention.pdf
- 2002.08 - B. Calcium-D-glucarate.pdf
- 2007.01 - C. Induction of apoptosis by calcium D-glucarate in 7,12-dimethyl benz [a] anthracene-exposed mouse skin.pdf
- 2008.09 - D. The biological role of D-glucaric acid and its derivatives - Potential use in medicine.pdf
- 2011.01 - E. Dietary D-glucarate effects on the biomarkers of inflammation during early post-initiation stages of benzo a pyrene-induced lung tumorigenesis in A J mice.pdf
6Diindolylmethane
- 2010.03 - F. Oral diindolylmethane (DIM) - Pilot evaluation ofa nonsurgical treatment for cervical dysplasia.pdf
- 2014.05 - A. Attenuation of Carcinogenesis and the Mechanism Underlying by the Influence of Indole-3-carbinol and Its Metabolite 3,3′-Diindolylmethane - A Therapeutic Marvel.pdf
- 2016.01 - B. Indole-3-Carbinol and Its Role in Chronic Diseases.pdf
- 2016.07 - C. Chemopreventive properties of 3,3′-diindolylmethane in breast cancer - Evidence from experimental and human studies.pdf
- 2017.10 - D. 3,3'-Diindolylmethane suppresses high-fat diet-induced obesity through inhibiting adipogenesis of pre-adipocytes by targeting USP2 activity.pdf
- 2018.07 - E. 3,3'-Diindolylmethane Enhances Glucose Uptake Through Activation of Insulin Signaling in 3T3-L1 Adipocytes.pdf
Drugs
4Antidepressants - Suicide Risks
- 2006.03 - A. Suicidality in Pediatric Patients Treated With Antidepressant Drugs.pdf
- 2007.06 - B. Expanding the Black Box - Depression, Antidepressants, and the Risk of Suicide.pdf
- 2009.08 - C. Risk of suicidality in clinical trials of antidepressants in adults.pdf
- 2016.09 - D. Antidepressants and Suicidality.pdf
COVID-19
13Prevention
- 2015.01 - The Omega-3 Fatty Acid Docosahexaenoic Acid ModulatesInflammatory Mediator Release in Human Alveolar Cells Exposed to Bronchoalveolar Lavage Fluid of ARDS Patients.pdf
- 2019.05 - Omega-3 polyunsaturated fatty acids in critically illpatients with acute respiratory distress syndrome - A systematic review and meta-analysis.pdf
- 2020.02 - Potential interventions for novel coronavirus in China - A systematic review.pdf
- 2020.03 - Can Bioactive Lipids Inactivate Coronavirus (COVID-19).pdf
- 2020.03 - ESPEN expert statements and practical guidance for nutritional management of individuals with SARS-CoV-2 infection.pdf
- 2020.03 - Early nutritional supplementation in non-critically ill patients hospitalized for the 2019 novel coronavirus disease (COVID-19).pdf
- 2020.04 - COVID-19 and vitamin D—Is there a link and an opportunity for intervention.pdf
- 2020.04.02 - Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths.pdf
- 2020.04.03 - Optimisation of Vitamin D status for enhanced immune-protection against Covid-19.pdf
- 2020.04.03 - Virtual screening and repurposing of FDA approved drugs against COVID-19 T main protease.pdf
- 2020.04.21 - COVID-19 - Potential of Microalgae Derived NaturalAstaxanthin As Adjunctive Supplement in Alleviating Cytokine Storm.pdf
- 2020.04.23 - Optimal Nutritional Status for a Well-Functioning Immune System Is an Important Factor to Protect against Viral Infections.pdf
- 2020.04.23 - Vitamin D supplementation could possibly improve clinical outcomes of patients infected with Coronavirus-2019 (COVID-19).pdf
Nutrients
6Ashwagandha
4Astaxanthin
- 2016.01 - A. Potential Anti-Atherosclerotic Properties of Astaxanthin.pdf
- 2017.02 - B. Neuroprotective mechanisms of astaxanthin - A potential therapeutic role in preserving cognitive function in age and neurodegeneration.pdf
- 2018.01 - C. Astaxanthin in Exercise Metabolism, Performance and Recovery - A Review.pdf
- 2018.04 - D. Astaxanthin in Skin Health, Repair, and Disease - A Comprehensive Review.pdf
4Benfotiamine
- 2013.12 - A. Double-blind, randomized placebo-controlled clinical trial of benfotiamine for severe alcohol dependence.pdf
- 2015.09 - B. Benfotiamine upregulates antioxidative system in activated BV-2 microglia cells.pdf
- 2016.12 - C. Long-Term Cognitive Improvement After Benfotiamine Administration in Patients with Alzheimer’s Disease.pdf
- 2017.10 - D. Advances in the management of diabetic neuropathy.pdf
8Beta-Cryptoxanthin
- 2012.04 - A. Role of carotenoid beta-cryptoxanthin in bone homeostasis.pdf
- 2015.07 - B. Beta-cryptoxanthin as a source of vitamin A.pdf
- 2016.02 - C. Absorption, metabolism, and functions of beta-cryptoxanthin.pdf
- 2017.04 - D. Nonalcoholic Fatty Liver Disease and Insulin Resistance - New Insights and Potential New Treatments.pdf
- 2017.05 - E. Daily oral intake of β-cryptoxanthin ameliorates neuropathic pain.pdf
- 2017.07 - F. Amelioration of the Development of Osteoarthritis by Daily Intake of Beta-Cryptoxanthin.pdf
- 2017.09 - G. Beta-Cryptoxanthin ameliorates metabolic risk factors by regulating NF-κB and Nrf2 pathways in insulin resistance induced by high-fat diet in rodents.pdf
- 2017.10 - H. Beta-Cryptoxanthin exerts greater cardioprotective effects on cardiac ischemia-reperfusion injury than astaxanthin by attenuating mitochondrial dysfunction in mice.pdf
1Borage Seed Oil
4Boron
5Calcium
7Coenzyme Q10
7EPA DHA
2Evening Primrose Oil
4Flax Seed Oil
- 2015.04 - A. Flaxseed - A potential functional food source.pdf
- 2016.03 - B. Effect of Flaxseed Intervention on Inflammatory Marker C-Reactive Protein - A Systematic Review and Meta-Analysisof Randomized Controlled Trials.pdf
- 2018.04 - C. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome - A Randomized, Double-Blind, Placebo-Controlled Trial.pdf
- 2019.01 - D. A systematic review and meta-analysis of clinicaltrials investigating the effects of flaxseed supplementation onplasma C-reactive protein concentrations.pdf
6Fucosyllactose
- 2013.11 - A. The Human Milk Metabolome Reveals Diverse Oligosaccharide Profiles.pdf
- 2013.12 - F. 2′-fucosyllactose - An abundant, genetically determined soluble glycan present in human milk.pdf
- 2016.10 - B. Oral supplementation of healthy adults with 2'-O-fucosyllactose and lacto-N-neotetraose is well tolerated and shifts the intestinal microbiota.pdf
- 2016.10 - C. The human milk oligosaccharide 2'-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine.pdf
- 2017.04 - D. FUT2-dependent breast milk oligosaccharides and allergy at 2 and 5 years of age in infants with high hereditary allergy risk.pdf
- 2019.07 - E. Immunomodulatory and Prebiotic Effects of 2'-Fucosyllactose in Suckling Rats.pdf
3GLA
5Glutathione
3Glycine
- 2017.03 - A. Multifarious Beneficial Effect of Nonessential Amino Acid, Glycine - A Review.pdf
- 2018.04 - B. Dietary Glycine Is Rate-Limiting for Glutathione Synthesis and May Have Broad Potential for Health Protection.pdf
- 2019.06 - C. Glycine Metabolism and Its Alterations in Obesityand Metabolic Diseases.pdf
2Hemp Seed Oil
6Hydroxy-Methylbutyrate
- 2015.07 - A. Usefulness of Î’-hydroxy-Î’-methylbutyrate (HMB) Supplementation in Different Sports - An Update and Practical Implication.pdf
- 2015.09 - B. Effect of beta-hydroxy-beta-methylbutyrate supplementation on muscle loss in older adults - A systematic review and meta-analysis.pdf
- 2018.01 - C. Role of Oral Nutritional Supplements Enriched with β-Hydroxy-β-Methylbutyrate in Maintaining Muscle Function and Improving Clinical Outcomes in Various Clinical Settings.pdf
- 2018.04 - D. The Effects of Beta-Hydroxy-Beta-Methylbutyrate Supplementation on Recovery Following Exercise-Induced Muscle Damage - A Systematic Review and Meta-Analysis.pdf
- 2018.05 - E. Is β-hydroxy β-methylbutyrate an effective anabolic agent to improve outcome in older diseased populations.pdf
- 2018.07 - F. Pre-exercise β-hydroxy-β-methylbutyrate free-acid supplementation improves work capacity recovery - A randomized, double-blinded, placebo-controlled study.pdf
8Iodine
8Iron
6L-Carnitine
- 2017.03 - A. L-carnitine treatment of insulin resistance - A systematic review and meta-analysis.pdf
- 2017.04 - B. Efficacy and Safety of L-Carnitine Treatment for Chronic Heart Failure - A Meta-Analysis of Randomized ControlledTrials.pdf
- 2017.05 - C. L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain.pdf
- 2017.08 - D. Significance of L-Carnitine for Human Health.pdf
- 2018.01 - E. Role of L-carnitine in female infertility.pdf
- 2018.03 - F. L-Carnitine Supplementation in Recovery after Exercise.pdf
8Lipoic Acid
- 2014.03 - G. Lipoic acid prevents fructose-induced changes in liver carbohydrate metabolism - Role of oxidative stress.pdf
- 2015.12 - H. α-Lipoic acid as a triglyceride-lowering nutraceutical.pdf
- 2017.11 - A. Biochemical and clinical relevance of alpha lipoic acid - Antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential.pdf
- 2018.06 - B. The Beneficial Effects of α-Lipoic Acid in Critically Ill Patients - A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.pdf
- 2018.08 - C. A Case for Alpha-Lipoic Acid as an Alternative Treatment for Diabetic Polyneuropathy.pdf
- 2018.09 - D. Alpha-lipoic acid preserves skeletal muscle mass in type 2 diabetic OLETF rats.pdf
- 2018.10 - E. The effects of alpha-lipoic acid supplementation on glucose control and lipid profiles among patients with metabolic diseases- A systematic review and meta-analysis of randomized controlled trials.pdf
- 2018.11 - F. Alpha-lipoic acid regulates the autophagy of vascular smooth muscle cells in diabetes by elevating hydrogen sulfide level.pdf
3Lutein
8Lycopene
- 2001.08 - Crohn disease.png
- 2010.06 - Small intestine antioxidant.png
- 2015.03 - A. Lycopene improves the distorted ratio between AA-DHA in the seminal plasma of infertile males and increases the likelihood of successful pregnancy.pdf
- 2015.12 - B. Natural products for chemoprevention of breast cancer.pdf
- 2016.08 - C. Protective effect of lycopene on high-fat diet-induced cognitive impairment in rats.pdf
- 2016.09 - ulcerative colitis.png
- 2017.12 - D. Increased dietary and circulating lycopene are associated with reduced prostate cancer risk - A systematic review and meta-analysis.pdf
- 2018.04 - E. Can lycopene be considered an effective protection against cardiovascular disease.pdf
11Magnesium
5Manganese
- 2013.11 -A. Manganese in Health and Disease.pdf
- 2018.04 - B. The Essential Element Manganese, Oxidative Stress, and Metabolic Diseases - Links and Interactions.pdf
- 2019.01 - C. Manganese - Its Role in Disease and Health.pdf
- 2019.09 - D. The role of zinc, copper, manganese and iron in neurodegenerative diseases.pdf
- 2019.10 - E. New Insights on the Role of Manganese in Alzheimer’s Disease and Parkinson’s Disease.pdf
3Molybdenum
3N-Acetyl-Cysteine
8Omegas
4PQQ
- 2013.12 - A. Dietary pyrroloquinoline quinone (PQQ) alters indicators of inflammation and mitochondrial-related metabolism in human subjects.pdf
- 2017.04 - B. Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice.pdf
- 2019.09 - C. PQQ ameliorates skeletal muscle atrophy, mitophagy and fiber type transition induced by denervation via inhibition of the inflammatory signaling pathways.pdf
- 2019.12 - D. Effects of Pyrroloquinoline Quinone (PQQ) Supplementation on Aerobic Exercise Performance and Indices of Mitochondrial Biogenesis in Untrained Men.pdf
5Pregnenolone DHEA
1Protein Shake
3Resveratrol
54Selenium
- 0 A. Selenium and human health
- 1 Autoimmune Thyroiditis.png
- 1 B Selenium.pdf
- 2 Autoimmune Thyroiditis.png
- 3 Autoimmune Thyroiditis.png
- 3 autoimmune thyroiditis.png
- 4 Autoimmune Thyroiditis.png
- 4 autoimmune thyroiditis.png
- 5 Autoimmune Thyroiditis.png
- 6 Autoimmune Thyroiditis.png
- 6 autoimmune thyroiditis.png
- 7 Autoimmune Thyroiditis.png
- 7 autoimmune thyroiditis.png
- 8 Autoimmune Thyroiditis.png
- 8 autoimmune thyroiditis.png
- 9 Autoimmune Thyroiditis.png
- 9 autoimmune thyroiditis.png
- 10 Autoimmune Thyroiditis.png
- 10 autoimmune thyroiditis.png
- 11 Autoimmune Thyroiditis.png
- 11 autoimmune thyroiditis.png
- 12 Autoimmune Thyroiditis.png
- 12 autoimmune thyroiditis.png
- 13 Autoimmune Thyroiditis.png
- 13 autoimmune thyroiditis.png
- 14 Inflammatory Bowel Disease.png
- 14 autoimmune thyroiditis.png
- 15 Inflammatory Bowel Disease.png
- 16 Inflammatory Bowel Disease.png
- 17 Inflammatory Bowel Disease.png
- 18 Inflammatory Bowel Disease.png
- 19 Inflammatory Bowel Disease.png
- 20 Crohn's Disease.png
- 21 Crohn's Disease.png
- 23 autoimmune thyroiditis.png
- 24 autoimmune thyroiditis.png
- 27 inflammatory bowel disease.png
- 28 inflammatory bowel disease.png
- 29 inflammatory bowel disease.png
- 30 inflammatory bowel disease.png
- 31 inflammatory bowel disease IDEM35.png
- 32 Crohn's disease.png
- 33 Crohn's disease.png
- 34 Inflammatory Bowel Diseases.png
- 35 Inflammatory Bowel Diseases.png
- 36 Inflammatory Bowel Diseases.png
- 2003.05 - A2. Characterization of Mammalian Selenoproteomes.pdf
- 2012.03 - A1. Selenium and human health.pdf
- 2012.03 - B2. Selenium and Human Health.pdf
- 2015.04 - B1. Selenium - An element for life.pdf
- 2015.05 - C. Selenium and Chronic Diseases - A Nutritional Genomics Perspective.pdf
- 2016.12 - D. Dietary Selenium and Human Health.pdf
- 2017.06 - F. Myo-inositol plus selenium supplementation restores euthyroid state in Hashimoto’s patients with subclinical hypothyroidism.pdf
- 2019.06 - E. Selenium supplementation in patients with subclinical hypothyroidism affected by autoimmune thyroiditis - Resultsof the SETI study.pdf
Oxidative Stress
58-OH-dG
- 2004.01 - A. Urinary 8-OHdG - A marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics.pdf
- 2009.04 - B. 8-hydroxy-2'-deoxyguanosine (8-OHdG) - A critical biomarker of oxidative stress and carcinogenesis.pdf
- 2015.08 - C. Transcriptional mutagenesis by 8-oxodG in α-synuclein aggregation and the pathogenesis of Parkinson's disease.pdf
- 2016.04 - D. 8-Hydroxy-2-Deoxyguanosine Levels and Cardiovascular Disease - A Systematic Review and Meta-Analysis of the Literature.pdf
- 2017.03 - E. 8-Hydroxy-2-deoxyguanosine levels and heart failure - A systematic review and meta-analysis of the literature.pdf
5Glymphatic System
- 2013.10 - A. Sleep drives metabolite clearance from the adult brain.pdf
- 2015.12 - B. The Glymphatic System - A Beginner's Guide.pdf
- 2017.09 - C. Understanding the functions and relationships of the glymphatic system and meningeal lymphatics.pdf
- 2018.01 - D. The Glymphatic System in Central Nervous System Health and Disease - Past, Present, and Future.pdf
- 2018.07 - E. The Glymphatic System and Waste Clearance with Brain Aging - A Review.pdf
6Inflammation
- 2009.01 - A. Chronic Inflammation and Oxidative Stress as a Major Cause of Age-Related Diseases and Cancer.pdf
- 2013.03 - C. The Role of Metallothionein in Oxidative Stress.pdf
- 2013.10 - B. Biological markers of oxidative stress - Applications to cardiovascular research and practice.pdf
- 2015.04 - E. Oxidative stress - A concept in redox biology andmedicine.pdf
- 2016.07 - D. An Update on Inflamm-Aging - Mechanisms, Prevention, and Treatment.pdf
- 2017.09 - F. Oxidative Stress in Atherosclerosis.pdf
5Myeloperoxidase
- 2008.02 - A. Melatonin is a potent inhibitor for myeloperoxidase.pdf
- 2010.08 - B. Reduction of Myeloperoxidase Activity by Melatonin and Pycnogenol May Contribute to their Blood Pressure LoweringEffect.pdf
- 2014.06 - C. Association of myeloperoxidase with total and cardiovascular mortality in individuals undergoing coronary angiography.pdf
- 2016.06 - D. Association between serum myeloperoxidase levels and coronary artery disease in patients without diabetes, hypertension, obesity, and hyperlipidemia.pdf
- 2018.06 - E. Myeloperoxidase as an Active Disease Biomarker - Recent Biochemical and Pathological Perspectives.pdf
20Oxidized-LDL
- 2000.05 - S. Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice.pdf
- 2001.02 - A. Vitamin E and Atherosclerosis - Beyond Prevention of LDL Oxidation.pdf
- 2004.02 - I. The hypolipidemic natural product Commiphora mukul and its component guggulsterone inhibit oxidative modification of LDL.pdf
- 2004.11 - N. Severe periodontitis enhances macrophage activation via increased serum lipopolysaccharide.pdf
- 2005.07 - K. Plasma oxidized low-density lipoprotein, a strongpredictor for acute coronary heart disease events in apparentlyhealthy, middle-aged men from the general population.pdf
- 2006.03 - M. Suppression of LDL Oxidation by Garlic Compounds Is a Possible Mechanism of Cardiovascular Health Benefit.pdf
- 2006.05 - Q. Protective effects of honokiol against oxidized LDL-induced cytotoxicity and adhesion molecule expression in endothelial cells.pdf
- 2008.07 - B. Oxidation of LDL and its clinical implication.pdf
- 2008.08 - C. Mulberry anthocyanin extracts inhibit LDL oxidation and macrophage-derived foam cell formation induced by oxidative LDL.pdf
- 2011.06 - P. Marine Carotenoids and Cardiovascular Risk Markers.pdf
- 2012.04 - D. Vitamin E ameliorates ox-LDL-induced foam cells formation through modulating the activities of oxidative stress-induced NF-κB pathway.pdf
- 2013.01 - E. Effects of coenzyme Q(10) on LDL oxidation in vitro.pdf
- 2015.11 - L. N-acetylcysteine inhibits in vivo oxidation of native low-density lipoprotein.pdf
- 2016.06 - J. Increased iron levels and lipid peroxidation in aMediterranean population of Spain.pdf
- 2017.05 - O. Endotoxin, Toll-like Receptor-4, and Atherosclerotic Heart Disease.pdf
- 2017.08 - F. Psoriasis and Cardiovascular Risk - Do Promising New Biomarkers Have Clinical Impact.pdf
- 2017.09 - T. Additional consumption of one egg per day increases serum lutein plus zeaxanthin concentration and lowers oxidized low-density lipoprotein in moderately hypercholesterolemic males.pdf
- 2017.12 - G. Association Between Circulating Oxidized LDL and Atherosclerotic Cardiovascular Disease - A Meta-analysis of Observational Studies.pdf
- 2018.04 - H. Oxidized low density lipoproteins - The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders.pdf
- 2018.05 - R. Oxidized LDL triggers changes in oxidative stressand inflammatory biomarkers in human macrophages.pdf
Diet
8Cholesterol
- 2022.01 - Role of Cholesterolâ€Associated Steatohepatitis in the Development of NASH.pdf
- 2022.07 - Serum Cholesterol Levels and Risk of Cardiovascular Death - A Systematic Review and a Dose-Response Meta-Analysis of Prospective Cohort Studies.pdf
- 2022.08 - Association of Low-Density Lipoprotein Cholesterol Levels with More than 20-Year Risk of Cardiovascular and All-Cause Mortality in the General Population.pdf
- 2023.01 - Oxidized low-density lipoprotein associates with cardiovascular disease by a vicious cycle of atherosclerosis and inflammation - A systematic review and meta-analysis.pdf
- 2023.06 - The lack of association between different LDLâ€C levels and oxidized LDL in patients with type 2 diabetes .pdf
- 2023.08 - L’apolipoproteÌine B dans l’eÌvaluation du risque cardiovasculaire.pdf
- 2024.01 - Non-HDL cholesterol and residual risk of cardiovascular events in patients with ischemic heart disease and well-controlled LDL cholesterol - A cohort study.pdf
- 2024.05 - Dietary fats and the APOE-e4 risk allele in relation to cognitive decline - A longitudinal investigation in a biracial population sample***.pdf
18Intermittent Fasting
- 2014.02 - Fasting - Molecular Mechanisms and Clinical Applications.pdf
- 2014.12 - Diet and feeding pattern affect the diurnal dynamics of the gut microbiome.pdf
- 2018.06 - Early Time-Restricted Feeding Improves Insulin Sensitivity, Blood Pressure, and Oxidative Stress Even without Weight Loss in Men with Prediabetes.pdf
- 2019.01 - Effect of breakfast on weight and energy intake - Systematic review and meta-analysis of randomised controlled trials.pdf
- 2019.03 - Caloric Restriction Mimetics against Age-Associated Disease - Targets, Mechanisms, and Therapeutic Potential.pdf
- 2019.06 - Time-Restricted Eating to Prevent and Manage Chronic Metabolic Diseases.pdf
- 2019.12 - Effects of Intermittent Fasting on Health, Aging, and Disease.pdf
- 2022.06 - The Effects of Time-Restricted Eating on Metabolism and Gut Microbiota - A Real-Life Study.pdf
- 2022.07 - A meta-analysis comparing the effectiveness of alternate day fasting, the 5-2 diet, and time-restricted eating for weight loss.pdf
- 2022.07 - Impact of early time-restricted eating on diet quality, meal frequency, appetite, and eating behaviors- A randomized trial.pdf
- 2022.10 - Time-restricted eating with or without low- carbohydrate diet reduces visceral fat and improves metabolic syndrome - A randomized trial.pdf
- 2022.11 - Early Time-Restricted Eating Reduces Weight and Improves Glycemic Response in Young Adults.pdf
- 2022.11 - The effects of time-restricted eating on sleep, cognitive decline, and Alzheimer's disease.pdf
- 2023.06 - The Effect of Intermittent Fasting on Appetite- A Systematic Review and Meta-Analysis.pdf
- 2023.07 - Effect of an Intermittent Calorie-restricted Diet on Type 2 Diabetes Remission - A Randomized Controlled Trial.pdf
- 2023.10 - Effect of Time-Restricted Eating versus Daily Calorie Restriction on Mood and Quality of Life in Adults with Obesity.pdf
- 2023.10 - Intermittent Fasting as a Potential Therapeutic Instrument for Major Depression Disorder- A Systematic Review of Clinical and Preclinical Studies.pdf
- 2024.08 - Blood metabolites mediate effects of breakfast skipping on heart failure via Mendelian randomization analysis.pdf
7Ketogenic Diet
- 2019.01 - Ketogenic diet rescues cognition in ApoE4þ patient with mild Alzheimer's disease - A case study.pdf
- 2020.06 - Cholesterol and Alzheimer’s Disease Risk - A Meta-Meta-Analysis***.pdf
- 2021.04 - Precision Nutrition for Alzheimer’s Prevention in ApoE4 Carriers.pdf
- 2021.06 - Effects of Evolution, Ecology, and Economy on Human Diet- Insights from Hunter-Gatherers and Other Small-Scale Societies.pdf
- 2021.06. Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects.pdf
- 2023.12 - APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry.pdf
- 2024.08 - Ketogenic diet but not free-sugar restriction alters glucose tolerance, lipid metabolism, peripheral tissue phenotype, and gut microbiome (RCT).pdf
Genomics
20AMY1A Polymorphism
- 2007.10 - Diet and the evolution of human amylase gene copy number variation.pdf
- 2012.01 - Genetic polymorphisms in carnitine palmitoyltransferase 1A gene are associated with variation in body composition and fasting lipid traits in Yup'ik Eskimos.pdf
- 2013.11 - Plant foods in the Upper Palaeolithic at DolniÌ Vӗstonice.pdf
- 2014.01 - The complete genome sequence of a Neandertal from the Altai Mountains.pdf
- 2016.11 - Selective sweep on human amylase genes postdates the split with Neanderthals.pdf
- 2017.06 - Starch Digestion–Related Amylase Genetic Variant Affects 2-Year Changes in Adiposity in Response to Weight-Loss Diets.pdf
- 2018.12 - Perspective - DNA Copy Number Variations in Cardiovascular Diseases.pdf
- 2019.04 - Human Salivary Amylase Gene Copy Number Impacts Oral and Gut Microbiomes.pdf
- 2019.04 - Human Salivary Amylase Gene Copy Number Impacts Oral and Gut Microbiomes.pdf
- 2020.04 - Salivary AMY1 Copy Number Variation Modifies Age-Related Type 2 Diabetes Risk.pdf
- 2020.11 - Alpha-amylase 1A copy number variants and the association with memory performance and Alzheimer’s dementia.pdf
- 2021.01 - Interaction Effect Between Copy Number Variation in Salivary Amylase Locus (AMY1) and Starch Intake on Glucose Homeostasis in the Malmö Diet and Cancer Cohort.pdf
- 2021.02 - DNA copy number variation - Main characteristics, evolutionary significance, and pathological aspects.pdf
- 2021.06 - Influence of AMY1A copy number variations on obesity and other cardiometabolic risk factors - A review of the evidence - abstract.pdf
- 2021.07 - VariabiliteÌ et eÌvolution du pheÌnotype quantiteÌ d’amylase salivaire.pdf
- 2022.05 - Impact of salivary and pancreatic amylase gene copy numbers on diabetes, obesity, and functional profiles of microbiome in Northern Japanese population.pdf
- 2023.12 - Dental caries prevalence and severity positively associate with AMY1 gene copy number - abstract.pdf
- 2024.09 - Recurrent evolution and selection shape structural diversity at the amylase locus.pdf
- 2024.10 - Global diversity, recurrent evolution, and recent selection on amylase structural haplotypes in humans.pdf
- 2024.10 - Reconstruction of the human amylase locus reveals ancient duplications seeding modern-day variation.pdf
1ApoC3 Polymorphism
60ApoE Polymorphism
- 1995.01 - O. Apolipoprotein E Isoform Phenotype and LDL Subclass Response to a Reduced-Fat Diet.pdf
- 1995.11 - Apolipoprotein E allele frequencies in a South African Indian female population - abstract - edited.pdf
- 1996.11 - The apolipoprotein E polymorphism in Greenland Inuit in its global perspective - abstract.pdf
- 1997.08 - High Frequency of the Apolipoprotein E *4 Allele in African Pygmies and Most of the African Populations in Sub-Saharan Africa.pdf
- 1997.12 - Absence of the E2 allele of apolipoprotein in Amerindians.pdf
- 1999.08 - Heterogeneity of the frequency of the apolipoprotein E-epsilon 4 allele in the European population - abstract - edited.pdf
- 2004.03 - U. Meat-adaptive genes and the evolution of slower aging in humans - abstract edited.pdf
- 2004.10 - A. The effect of dietary fat on LDL size is influenced by apolipoprotein E genotype in healthy subjects.pdf
- 2006.01 - D. APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians.pdf
- 2006.01 - E. Cholesterol, APOE genotype, and Alzheimer disease.pdf
- 2006.12 - H. Apolipoprotein E e4 Allele Affects Risk of Hyperhomocysteinemia in the Elderly.pdf
- 2010.04 - B. Selection on Alleles Affecting Human Longevity and Late-Life Disease - The Example of Apolipoprotein E.pdf
- 2010.05 - R. Apolipoprotein E Allelic Frequency Altered in Women with Early-onset Breast Cancer.pdf
- 2011.03 - I. The emergence of human-evolutionary medical genomics.pdf
- 2011.03 - J. How evolutionary principles improve the understanding of human health and disease.pdf
- 2012.05 - K. Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition.pdf
- 2012.10 - S. The Apolipoprotein E (APOE) Gene Appears Functionally Monomorphic in Chimpanzees (Pan troglodytes).pdf
- 2013.05 - G. APOE genotype modifies the association between plasma omega-3 fatty acids and plasma lipids in the Multi-Ethnic Study of Atherosclerosis (MESA).pdf
- 2014.05 - T. Exercise, APOE genotype, and the evolution of the human lifespan.pdf
- 2014.09 - Q. Dietary fat composition and dementia risk.pdf
- 2016.02 - L. High-Fat Diet Changes Hippocampal Apolipoprotein E (apoE).pdf
- 2016.03 - F. Impact of Genotype on EPA and DHA Status and Responsiveness to Increased Intakes.pdf
- 2016.06 - Apolipoprotein E - From cardiovascular disease to neurodegenerative disorders.pdf
- 2016.10 - Apolipoprotein E Gene Variants and Risk of Coronary Heart Disease - A Meta-Analysis.pdf
- 2017.03 - C. Apolipoprotein E4 and Insulin Resistance Interact to Impair Cognition and Alter the Epigenome and Metabolome.pdf
- 2017.06 - Evolution of human apolipoprotein E (APOE) isoforms-Gene structure, protein function and interaction with dietary factors.pdf
- 2017.06 - M. Apolipoprotein E - A Multifunctional Protein with Implications in Various Pathologies.pdf
- 2017.07 - N. ApoE Genotype Influences Insulin Resistance.pdf
- 2017.12 - P. Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction.pdf
- 2018.04 - V. Association of apolipoprotein E gene polymorphisms with blood lipids and their interaction with dietary factors.pdf
- 2018.10 - W. Clinical Application of APOE in Alzheimer's Prevention - A Precision Medicine Approach.pdf
- 2019.01 - Ketogenic diet rescues cognition in ApoE4þ patient with mild Alzheimer's disease - A case study (K).pdf
- 2019.01 - X. The ApoE ε4 Isoform - Can the Risk of Diseases be Reduced by Environmental Factors?.pdf
- 2019.01 - Y. Modulating Effect of Diet on Alzheimer’s Disease.pdf
- 2019.03 - The Genetic Variability of APOE in Different Human Populations and Its Implications for Longevity (Burkina Faso).pdf
- 2019.04 - APOE genotype influences the gut microbiome structure and function in humans and mice.pdf
- 2019.11 - ApoE4-Induced Cholesterol Dysregulation and Its Brain Cell Type-Specific Implications in the Pathogenesis of Alzheimer’s Disease (K).pdf
- 2020.06 - Cholesterol and Alzheimer’s Disease Risk - A Meta-Meta-Analysis (K).pdf
- 2020.06 - Refined carbohydrate-rich diet is associated with long-term risk of dementia and Alzheimer’s disease in apolipoprotein E 4 allele carriers.pdf
- 2020.08 - ApolipoproteinE (APOE) genotype-associated disease risks- aphenome-wide, registry-based, case-control study utilising the UK Biobank.pdf
- 2020.10 - APOE2 is associated with longevity independent of Alzheimer’s disease.pdf
- 2020.11 - APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community Cohort.pdf
- 2021.04 - Age and sex specific effects of APOE genotypes on ischemic heart disease and its risk factors in the UK Biobank.pdf
- 2021.04 - Precision Nutrition for Alzheimer’s Prevention in ApoE4 Carriers (K).pdf
- 2021.04 - Precision Nutrition for Alzheimer’s Prevention in ApoE4 Carriers.pdf
- 2021.06. Cholesterol and Alzheimer’s Disease; From Risk Genes to Pathological Effects (K).pdf
- 2021.07 - APOE Genotype and Alzheimer’s Disease - The Influence of Lifestyle and Environmental Factors.pdf
- 2021.10 - Apolipoprotein E and Alzheimer’s disease.pdf
- 2022.11 - Associations of Alzheimer Disease–Protective APOE Variants With Age-Related Macular Degeneration.pdf
- 2023.06 - Contribution of APOE Genetic Variants to Dyslipidemia (K).pdf
- 2023.08 - Alzheimer’s disease phenotype based upon the carrier status of the apolipoprotein E ε4 allele (K).pdf
- 2023.08 - Apolipoprotein-ε4 is associated with higher fecundity in a natural fertility population.pdf
- 2023.12 - APOE Genotype and Alzheimer Disease Risk Across Age, Sex, and Population Ancestry (K).pdf
- 2024.01 - The selection landscape and genetic legacy of ancient Eurasians.pdf
- 2024.02 - Apolipoprotein E-ε2 and Resistance to Atherosclerosis in Midlife- The PESA Observational Study.pdf
- 2024.03 - How are APOE4, changes in body weight, and longevity related? Insights from a causal mediation analysis.pdf
- 2024.05 - Dietary fats and the APOE-e4 risk allele in relation to cognitive decline - A longitudinal investigation in a biracial population sample.pdf
- 2024.07 - Apolipoprotein E and Alzheimer's disease pathology in African American older adults - edited.pdf
- High Cholesterol APOE Gene and Diet.pdf
- Steven Gundry - Dietary Management of the Apo E 4.pdf
2BDNF Polymorphism
2CBS Polymorphism
6COMT Polymorphism
- 2001.09 - C. Cathecol-O-Methyltransfera-mediated metabolism of cathecol estrogens.pdf
- 2005.06 - E. COMT Polymorphisms and Anxiety-Related Personality Traits.pdf
- 2006.06 - F. Associations between the COMT Val Met polymorphism early life stress and personality among healthy adults.pdf
- 2014.05 - B. COMT Val158Met and PPARγ Pro12Ala polymorphisms and susceptibility to Alzheimer's disease.pdf
- 2014.08 - D. Genetic polymorphisms affecting susceptibility to mercury neurotoxicity in children.pdf
- 2016.05 - A. Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer.pdf
4CPT1A Polymorphism
- 2009.04 - The paradox of the carnitine palmitoyltransferase type Ia P479L variant in Canadian Aboriginal populations - abstract.pdf
- 2012.01 - Genetic polymorphisms in carnitine palmitoyltransferase 1A gene are associated with variation in body composition and fasting lipid traits in Yup'ik Eskimos.pdf
- 2019.01 - Carnitine Palmitoyl Transferase, Type 1A (CPT1A) - The Arctic Variant - abstract.pdf
- 2023.12 - The CPT1A Arctic variant - Perspectives of community members and providers in two Alaska tribal health settings.pdf
4CTLA-4 Polymorphism
- 2005.09 - A. Genetic susceptibility in thyroid autoimmunity.pdf
- 2015.09 - D. CTLA-4 and MDR1 polymorphisms increase the risk for ulcerative colitis - A meta-analysis.pdf
- 2015.11 - B. Immunogenetics of Autoimmune Thyroid Diseases - A comprehensive Review.pdf
- 2017.01 - C. General and Specific Genetic Polymorphism of Cytokines-Related Gene in AITD.pdf
2CYP19A1 Polymorphism
2CYP1A1 Polymorphism
3CYP1A2 Polymorphism
3CYP1B1 Polymorphism
- 2010.02 - A. Association of CYP1B1 Polymorphisms with Breast Cancer - A Case-Control Study in the Han Population.pdf
- 2015.01 - B. Cytochrome P1B1 (CYP1B1) polymorphisms and cancer risk - A meta-analysis of 52 studies.pdf
- 2017.03 - C. Genetic polymorphisms of phase I metabolizing enzyme genes, their interaction with lifetime grilled and smoked meat intake, and breast cancer incidence.pdf
51DIO2 Polymorphism
- 1997.08 - High Frequency of the Apolipoprotein E*4 Allele in African Pygmies and Most of the African Populations in Sub-Saharan Africa.pdf
- 2002.02 - Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases.pdf
- 2009.04 - Novel insights into thyroid hormones from the study of common genetic variation.pdf
- 2009.05 - Association of genetic polymorphisms in the type II deiodinase gene with bipolar disorder.pdf
- 2009.05 - Common Variation in the DIO2 Gene Predicts Response to Combination Therapy in Hypothyroid Patients.pdf
- 2009.05 - For Some, L-Thyroxine Replacement Might Not Be Enough - A Genetic Rationale.pdf
- 2010.01 - Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes - Case–control study and meta-analysis.pdf
- 2010.02 - The Type 2 Deiodinase Thr92Ala Polymorphism and Bone Density.pdf
- 2010.06 - Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes - Case-control study and meta-analysis.pdf
- 2010.11 - The Thr92Ala 5' type 2 deiodinase gene polymorphism is associated with a delayed triiodothyronine secretion.pdf
- 2012.03 - Does Combination T4 and T3 therapy make sense.pdf
- 2012.06 - Thyroid hormone replacement therapy - three 'simple' questions, complex answers.pdf
- 2012.09 - Prevalence of Dio2T92A polymorphism and its association with thyroid autoimmunity.pdf
- 2014.01 - Earliest evidence for caries and exploitation of starchy plant foods in Pleistocene hunter-gatherers from Morocco.pdf
- 2014.03 - Paradigm shifts in thyroid hormone replacement therapies for hypothyroidism.pdf
- 2015.01 - Prevalent polymorphism in thyroid hormone-activating enzyme leaves a genetic fingerprint.pdf
- 2015.04 - Genetic determination of the hypothalamic-pituitary-thyroid axis - Where do we stand?.pdf
- 2015.05 - Type II deiodinase polymorphisms and serum thyroid hormone levels in patients with mild cognitive impairment.pdf
- 2015.06 - Association of the DIO2 gene single nucleotide polymorphisms with recurrent depressive disorder.pdf
- 2015.11 - Scope and limitations of iodothyronine deiodinases in hypothyroidism.pdf
- 2016.01 - The History and Future of Treatment of Hypothyroidism.pdf
- 2016.01 - Update on the treatment of hypothyroidism.pdf
- 2016.09 - The Type 2 Deiodinase Thr92Ala Polymorphism Is Associated with Worse Glycemic Control in Patients with Type 2 Diabetes Mellitus.pdf
- 2016.09 - Type 2 Deiodinase Disruption in Astrocytes Results in Anxiety-Depressive-Like Behavior in Male Mice.pdf
- 2016.10 - Is a Normal TSH Synonymous with Euthyroidism in Levothyroxine Monotherapy?.pdf
- 2016.11 - D2 Thr92Ala thyroid hormone levels and biochemical hypothyroidism in preeclampsia.pdf
- 2017.02 - D2-Thr92Ala, thyroid hormone levels and biochemical hypothyroidism in preeclampsia.pdf
- 2017.05 - DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients.pdf
- 2017.07 - Hypothyroid Patients Encoding Combined MCT10 and DIO2 Gene Polymorphisms May Prefer L-T3 L-T4 Combination Treatment.pdf
- 2017.12 - T4 T3 combination therapy - Is there a true effect?.pdf
- 2018.01 - Association between genetic polymorphism and levothyroxine bioavailability in hypothyroid patients.pdf
- 2018.02 - A Common DIO2 Polymorphism And Alzheimer's Disease Dementia in African And European Americans.pdf
- 2018.03 - Association between genetic polymorphism and levothyroxine bioavailability in hypothyroid patients.pdf
- 2018.07 - Pathophysiological relevance of deiodinase polymorphism.pdf
- 2018.08 - Clinical significance of type 2 iodothyronine deiodinase polymorphism.pdf
- 2019.01 - Type 2 deiodinase polymorphism causes ER stress and hypothyroidism in the brain.pdf
- 2019.08 - Individualised requirements for optimum treatment of hypothyroidism - Complex needs, limited options.pdf
- 2019.12 - Evolutionary basis for the human diet- consequences for human health.pdf
- 2020.01 - Iodothyronine deiodinases and reduced sensitivity to thyroid hormones.pdf
- 2020.05 - Thr92Ala polymorphism in the type 2 deiodinase gene- an evolutionary perspective.pdf
- 2020.06 - Targeting the right population for T3 T4 combined therapy- where are we now and where to next?.pdf
- 2021.06 - Comparative Effectiveness of Levothyroxine, Desiccated Thyroid Extract, and Levothyroxine Liothyronine in Hypothyroidism.pdf
- 2022.03 - Improvement of depression in a patient with hypothyroidism and deiodinase polymorphism with LT3 Therapy.pdf
- 2022.05 - Heterozygote Advantage of the Type II Deiodinase Thr92Ala Polymorphism on Intrahospital Mortality of COVID-19.pdf
- 2022.06 - Optimal Hormone Replacement Therapy in Hypothyroidism - A Model Predictive Control Approach.pdf
- 2022.09 - Association of Type 2 Deiodinase Thr92Ala Polymorphism with Pediatric Obesity in Japanese Children - A Case-Control Study.pdf
- 2023.02 - Type 2 deiodinase Thr92Ala polymorphism and aging are associated with a decreased pituitary sensitivity to thyroid hormone.pdf
- 2023.03 - Association between DIO2 Thr92Ala polymorphism and hypertension in patients with hypothyroidism - Korean Genome and Epidemiology Study.pdf
- 2023.04 - The Physiological Functions and Polymorphisms of Type II Deiodinase.pdf
- 2024.05 - Gene polymorphisms and thyroid hormone signaling - Implication for the treatment of hypothyroidism.pdf
- Breakthrough Discovery - Need for T3 could be genetic Dr Gary Pepper.pdf
5FADS1-2 Polymorphisms
- 2008.11 - Genetic variants of the FADS1 FADS2 gene cluster are associated with altered (n-6) and (n-3) essential fatty acids in plasma and erythrocyte phospholipids in women during pregnancy and in breast milk during lactation - abstract.png
- 2010.02 - Genetic variants of the FADS1 FADS2 gene cluster as related to essential fatty acid metabolism.pdf
- 2020.05 - Fatty acid profile and estimated desaturase activities in whole blood are associated with metabolic health.pdf
- 2020.09 - FADS genetic and metabolomic analyses identify the ∆5 desaturase (FADS1) step as a critical control point in the formation of biologically important lipid.pdf
- 2023.03 - Dietary Fatty Acids and Inflammation - Focus on the n-6 Series.pdf
31FUT2 Polymorphism
- 2010.06 - Fucosyltransferase 2 (FUT2) non-secretor status is associated with Crohn's disease (CD).pdf
- 2011.05 - Fucosyltransferase 2 non-secretor and low secretor status predicts severe outcomes in premature infants (NEC).pdf
- 2011.05 - Secretor Genotype (FUT2 gene) Is Strongly Associated with the Composition of Bifidobacteria in the Human Intestine (ID)°.pdf
- 2011.11 - FUT2 Nonfunctional Variant - A “Missing Link†Between Genes and Environment in Type 1 Diabetes? (ID)°.pdf
- 2014.09 - Innate lymphoid cells regulate intestinal epithelial cell glycosylation (ID).pdf
- 2014.11 - Reprograming of gut microbiome energy metabolism by the FUT2 Crohn’s disease risk polymorphism (CD).pdf
- 2015.03 - N. FUT2 - Filling the gap between genes and environment in Behçet's disease? - abstract.pdf
- 2015.04 - Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infants (ID)°.pdf
- 2015.06 - Fucosyltransferase 2 - A genetic risk factor for primary sclerosing cholangitis and Crohn's disease--a comprehensive review - abstract edited (CD)°.pdf
- 2016.05 - Gastric mucin glycosylation is shaped by FUT2 activity and functionally impacts Helicobacter pylori binding (HP).pdf
- 2016.11 - Epithelial glycosylation in gut homeostasis and inflammation (IBD).pdf
- 2017.06 - Recent advances in gut immunology (ID).pdf
- 2017.11 - Infection's sweet tooth - How glycans mediate infection and disease susceptibility (ID)°.pdf
- 2018.09 - FUT2 secretor genotype and susceptibility to infections and chronic conditions in the ALSPAC cohort.pdf
- 2018.09 - Review of the Clinical Experiences of Feeding Infants Formula Containing the Human Milk Oligosaccharide 2′-Fucosyllactose.pdf
- 2018.10 - Impact of carbohydrate substrate complexity on the diversity of the human colonic microbiota.pdf
- 2019.02 - FUT2 gene variants and reported respiratory and gastrointestinal illnesses during infancy.pdf
- 2019.12 - Fucosyltransferase Gene Polymorphisms and Lewisb-Negative Status Are Frequent in Swedish Newborns, With Implications for Infectious Disease Susceptibility and Personalized Medicine.pdf
- 2020.03 - The Impact of Human Genetic Polymorphisms on Rotavirus Susceptibility, Epidemiology, and Vaccine Take.pdf
- 2020.10 - Blends of Human Milk Oligosaccharides Confer Intestinal Epithelial Barrier Protection In Vitro.pdf
- 2020.12 - Can the FUT2 Non-secretor Phenotype Associated With Gut Microbiota Increase the Children Susceptibility for Type 1 Diabetes? A Mini Review.pdf
- 2021.03 - A comparison of the in vitro effects of 2'Fucosyllactose and lactose on the composition and activity of gut microbiota from infants and toddlers.pdf
- 2021.10 - 2'-Fucosyllactose ameliorates chemotherapy-induced intestinal mucositis by protecting intestinal epithelial cells against apoptosis.pdf
- 2021.10 - The Effects of Human Milk Oligosaccharides on Gut Microbiota, Metabolite Profiles and Host Mucosal Response in Patients with Irritable Bowel Syndrome.pdf
- 2022.01 - Recent advances on 2'-fucosyllactose - Physiological properties, applications, and production approaches.pdf
- 2022.06 - 2'-Fucosyllactose increases the abundance of Blautia in the presence of extracellular Fucosidase-possessing bacteria.pdf
- 2022.06 - FUT2 gene as a genetic susceptible marker of infectious diseases - A Review.pdf
- 2022.06 - Human Milk oligosaccharides and lactose differentially affect infant gut microbiota and intestinal barrier in vitro.pdf
- 2023.03 - Functional effects of human milk oligosaccharides (HMOs).pdf
- 2023.07 - An Extensively Hydrolyzed Formula Supplemented with Two Human Milk Oligosaccharides Modifies the Fecal Microbiome and Metabolome in Infants with Cow’s Milk Protein Allergy.pdf
- 2023.10 - Effects of 2'-fucosyllactose on the composition and metabolic activity of intestinal microbiota from piglets after in vitro fermentation.pdf
6GPX1 Polymorphism
- 2012.05 - A. Inherited variations in the SOD and GPX gene families and cancer risk.pdf
- 2014.10 - B. Polymorphisms of glutathione peroxidase 1 GPX1 Pro198Leu and catalase CAT C 262T in women with spontaneous abortion.pdf
- 2016.07 - C. Functional polymorphisms in antioxidant genes in Hurthle cell thyroid neoplasm - an association of GPX1 polymorphism and recurrent Hurthle cell thyroid carcinoma.pdf
- 2017.08 - D. Glutathione peroxidases as oncotargets.pdf
- 2018.10 - E. Genetic Polymorphisms of Catalase and GlutathionePeroxidase-1 in Keratoconus.pdf
- 2019.11 - F. Association of GPx1 P198L and CAT C-262T Genetic Variations With Polycystic Ovary Syndrome in Chinese Women.pdf
2GSTM1 Polymorphism
2GSTP1 Polymorphism
3GSTT1 Polymorphism
- 2009.11 - A. Functional genetic variants of glutathione S-transferase protect against serum ascorbic acid deficiency.pdf
- 2014.01 - B. GSTT1 genotype interacts with vitamin C intake to influence serum ascorbic acid levels.pdf
- 2018.01 - C. Polymorphism of glutathione S-transferase M1 and T1 genes and susceptibility to psoriasis disease.pdf
10LCT Polymorphism
- 2009.04 - Convergent adaptation of human lactase persistence in Africa and Europe.pdf
- 2009.08 - The Origins of Lactase Persistence in Europe.pdf
- 2012.07 - A. Lactose intolerance - Diagnosis, genetic, and clinical factors.pdf
- 2012.12 - An Evolutionary Whodunit - How Did Humans Develop Lactose Tolerance?.pdf
- 2014.04 - Genetic Origins of Lactase Persistence and the Spread of Pastoralism in Africa.pdf
- 2016.02 - B. Lactase persistence versus lactose intolerance - Is there an intermediate phenotype? - abstract edited.pdf
- 2017.06 - C. Lactose Intolerance (LCT-13910C>T) Genotype Is Associated with Plasma 25-Hydroxyvitamin D Concentrations in Caucasians - abstract edited.pdf
- 2017.06 - Country, regional, and global estimates for lactose malabsorption in adults - A systematic review and meta-analysis.pdf
- 2017.09 - The Relationship Between the Human Genome and Microbiome Comes into View.pdf
- 2020.09 - Genetics of Lactose Intolerance - An Updated Review and Online Interactive World Maps of Phenotype and Genotype Frequencies.pdf
3MAO-A Polymorphism
- 2013.08 - A. MAOA and MAOB polymorphisms and anger-related traits in suicidal participants and controls.pdf
- 2014.12 - C. Interaction between MAOA and FOXP2 in association with autism and verbal communication in a Korean population.pdf
- 2017.10 - B. Role of preferentially transmitted monoamine oxidase gene variants in behavioral problems of male ADHD probands.pdf
7MTHFR Polymorphism
- 2007.12 - G. Nutrigenomics - The Genome-Food Interface.pdf
- 2013.06 - F. Use of azathioprine and the risk of cancer in inflammatory bowel disease.pdf
- 2015.01 - A. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism - Epidemiology metabolism and the associated diseases.pdf
- 2016.08 - B. Association of MTHFR A1298C polymorphism with breast cancer and-or ovarian cancer risk - An updated meta-analysis.pdf
- 2016.11 - C. Geographical and ethnic distribution of MTHFR gene polymorphisms and their associations with diseases among Chinese population.pdf
- 2017.01 - D. MTHFR C677T polymorphism and breast ovarian cancer risk - A meta-analysis of 19 - 260 patients and 26364 controls.pdf
- 2017.06 - E. Investigation of Methylenetetrahydrofolate Reductase C677T Polymorphism and Human Papilloma Virus Genotypes in Iranian Breast Cancer.pdf
2MTR-MTRR Polymorphisms
3NQO1 Polymorphism
- 2014.12 - A. A Review of NAD(P)H Quinone Oxidoreductase 1 (NQO1) - A Multifunctional Antioxidant Enzyme.pdf
- 2017.08 - B. Functions of NQO1 in Cellular Protection and CoQ10 Metabolism and its Potential Role as a Redox Sensitive Molecular Switch.pdf
- 2017.09 - C. NQO1 C609T polymorphism and lung cancer susceptibility.pdf
7OGG1 Polymorphism
- 2013.10 - A. Genotype-phenotype analysis of S326C OGG1 polymorphism - Risk factor for oxidative pathologies.pdf
- 2013.10 - G. Alzheimer’s Disease Associated Polymorphisms in Human OGG1 Alter Catalytic Activity and Sensitize Cells to DNA Damage.pdf
- 2015.02 - B. A systematic review and meta-analysis of the association between OGG1 Ser326Cys polymorphism and cancers.pdf
- 2016.02 - C. Association between OGG1 Ser326Cys polymorphism and risk of upper aero-digestive tract and gastrointestinal cancers.pdf
- 2017.06 - D. Association between the 8-oxoguanine DNA glycosylase gene Ser326Cys polymorphism and age-related cataract.pdf
- 2017.07 - E. The hOGG1 Ser326Cys Gene Polymorphism and Breast Cancer Risk in Saudi Population.pdf
- 2018.01 - F. Effects of the Ser326Cys Polymorphism in the DNA Repair OGG1 Gene on Cancer, Cardiovascular, and All-Cause Mortality.pdf
3OLR1 Polymorphism
- 2015.12 - The Influence of OLR1 and PCSK9 Gene Polymorphisms on Ischemic Stroke - Evidence from a Meta-Analysis.pdf
- 2017.10 - Scavenger Receptor LOX1 Genotype Predicts Coronary Artery Disease in Patients With Familial Hypercholesterolemia.pdf
- 2018.07 - OLR1 Gene Polymorphism and Oxidized LDL Levels in Metabolic Syndrome in Indian Population.pdf
3PEMT Polymorphism
5PON1 Polymorphism
- 2010.03 - A. Protective Effect of Paraoxonase 1 Gene Variant Gln192Arg in Age-Related Macular Degeneration.pdf
- 2017.03 - B. PON1 L55M polymorphism might contribute to the risk of cancer.pdf
- 2017.10 - C. Organophosphate pesticides and PON1 L55M in Parkinson's disease progression.pdf
- 2017.10 - D. Role of polyphenols and polyphenol-rich foods in the modulation of PON1 activity and expression.pdf
- 2017.12 - E. Joint Effects of PON1 Polymorphisms and VegetableIntake on Ischemic Stroke - A Family-Based Case Control Study.pdf
6SOD2 Polymorphism
- 2005.04 - A. Is the Val16Ala manganese superoxide dismutase polymorphism associated with the aging process.pdf
- 2009.08 - B. Regulation of superoxide dismutase genes - Implications in disease.pdf
- 2014.08 - Manganese superoxide dismutase in carcinogenesis - Friend or foe?.pdf
- 2015.01 - C. Manganese superoxide dismutase and oxidative stress modulation.pdf
- 2015.09 - D. Superoxide dismutase 2 gene and cancer risk - Evidence from an updated meta-analysis.pdf
- 2019.09 - E. Decoding the role of SOD2 in sickle cell disease.pdf
2SULT1A1 Polymorphism
3SUOX Polymorphism
3TCF7L2 Polymorphism
- 2009.02 - Association between TCF7L2 gene polymorphisms and susceptibility to Type 2 Diabetes Mellitus - A large Human Genome Epidemiology (HuGE) review and meta-analysis.pdf
- 2009.04 - TCF7L2, dietary carbohydrate, and risk of type 2 diabetes in US women.pdf
- 2015.09 - Association of TCF7L2 Genetic Polymorphisms with Type 2 Diabetes Mellitus in the Uygur Population of China.pdf
14VDR Polymorphism
- 2005.01 - M. Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population.pdf
- 2009.11 - A. Vitamin D Receptor gene polymorphism may predict response to vitamin D intake and bone turnover (VD).pdf
- 2013.04 - B. Polymorphisms in the vitamin D receptor gene and risk of autoimmune thyroid diseases - A meta-analysis (HT).pdf
- 2013.05 - C. Vitamin D in the etiopathogenesis of autoimmune thyroiditis (HT).pdf
- 2013.06 - D. Vitamin D receptor gene ApaI, TaqI, FokI and BsmI polymorphisms in a group of Turkish patients with Hashimoto's thyroiditis (HT).pdf
- 2014.01 - L. Vitamin D Levels in Serum, Vitamin D Receptor Polymorphisms and Semen Quality Correlations.pdf
- 2014.07 - E. Environmental, personal, and genetic determinants of response to vitamin D supplementation in older adults (VD).pdf
- 2016.04 - F. Association of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D levels with Crohn's disease in Chinese patients (CD).pdf
- 2016.10 - G. Effects of Genetic and Nongenetic Factors on Total and Bioavailable 25(OH)D Responses to Vitamin D Supplementation (VD).pdf
- 2017.01 - H. Does vitamin D play a role in autoimmune endocrine disorders A proof of concept (HT).pdf
- 2017.01 - I. Vitamin D in Autoimmunity - Molecular Mechanisms and Therapeutic Potential (HT)(CD).pdf
- 2017.02 - J. The association between vitamin D receptor polymorphisms and serum 25-hydroxyvitamin D levels with ulcerative colitis in Chinese Han population (UC).pdf
- 2017.07 - K. Circulating 25-Hydroxy Vitamin D Relative to Vitamin D Receptor Polymorphism after Vitamin D3 Supplementation in Breast Cancer Women.pdf
- 2017.11 - N. Vitamin D Axis in Inflammatory Bowel Diseases - Role, Current Uses and Future Perspectives.pdf
4SIRT3
- 2011.03 - A. Sirtuins at a glance.pdf
- 2012.07 - B. Sirtuins 1 & 3 - physiological Modulators of Metabolism.pdf
- 2013.04 - The Role of Sirtuins in Alzheimer's Disease.pdf
- 2013.07 - C. Interaction of Sirt3 with OGG1 contributes to repair of mitochondrial DNA and protects from apoptotic cell death under oxidative stress.pdf
4Silicon
- 2007.03 - A. Silicon and bone health.pdf
- 2013.04 - B. Silicon - A Review of Its Potential Role in the Prevention and Treatment of Postmenopausal Osteoporosis.pdf
- 2014.11 - C. A review of the effects of dietary silicon intakeon bone homeostasis and regeneration.pdf
- 2016.05 - D. Use of silicon for skin and hair care - An approach of chemical forms available and efficacy.pdf
7Stearidonic Acid
- 2007.01 - A. Echium - A Source of Stearidonic Acid Adapted to the Northern Great Plains in the US.pdf
- 2008.07 - B. Echium oil - A valuable source of n-3 and n-6 fatty acids.pdf
- 2012.02 - C. Stearidonic acid as a pro-eicosapentaenoic acid.pdf
- 2013.02 - D. Stearidonic acid as a supplemental source of ω-3 polyunsaturated fatty acids to enhance status for improved human health.pdf
- 2013.05 - E. Dietary omega-3 PUFA and health - Stearidonic acid-containing seed oils as effective and sustainable alternativesto traditional marine oils.pdf
- 2016.01 - F. Consumption of Buglossoides arvensis seed oil is safe and increases tissue long-chain n-3 fatty acid content morethan flax seed oil.pdf
- 2017.09 - G. Unravelling a stearidonic acid- rich triacylglycerol biosynthetic pathway in the developing seeds of Buglossoidesarvensis.pdf
2Taurine
13Vitamin A
- 0 thyroid.png
- 1 thyroid.png
- 2 immunomodulation.png
- 3 immunomodulation.png
- 4 immunomodulation.png
- 5 autoimmune thyroiditis.png
- 12 inflammatory bowel disease IDEM26.png
- 13 inflammatory bowel disease.png
- 14 immunomodulation.png
- 24 Crohn's disease.png
- 25 Crohn's disease.png
- 26 Inflammatory Bowel Diseases.png
- 27 Inflammatory Bowel Diseases.png
12Vitamin B
4Vitamin B1
7Vitamin B12
9Vitamin B2
- 1 Iron Absorption.png
- 2 Iron Absorption.png
- 3 Iron Absorption.png
- 4 Immunity.png
- 5 Antioxidant.png
- 6 Intestinal Health.png
- 7 Intestinal Health.png
- 2020.04 - A. Impact of the MTHFR C677T polymorphism on one-carbon metabolites - Evidence from a randomised trial of riboflavinsupplementation.pdf
- 2020.04 - B. Riboflavin supplementation alters global and gene-specific DNA methylation in adults with the MTHFR 677 TT genotype.pdf
3Vitamin B3
2Vitamin B5
1Vitamin B6
3Vitamin B8
2Vitamin B9
4Vitamin C
- 2014.01 - A. Vitamin C.pdf
- 2016.09 - B. Vitamin C Status and Cognitive Function - A Systematic Review.pdf
- 2017.05 - C. Emerging Evidence on Neutrophil Motility Supporting Its Usefulness to Define Vitamin C Intake Requirements.pdf
- 2017.09 - D. Vitamin C Status and Cognitive Function - A Systematic Review.pdf
19Vitamin D
- 0 autoimmune thyroiditis.png
- 2 autoimmune thyroiditis.png
- 3 autoimmune thyroiditis.png
- 4 autoimmune thyroiditis.png
- 6 autoimmune thyroiditis.png
- 10 ulcerative colitis.png
- 11 ulcerative colitis
- 12 ulcerative colitis.png
- 13 inflammatory bowel disease.png
- 14 inflammatory bowel disease.png
- 15 inflammatory bowel disease.png
- 16 UC
- 26 UC
- 27 UC relapse.png
- 33 Crohn's disease.png
- 34 Crohn's disease.png
- 35 Inflammatory Bowel Diseases.png
- 36 Inflammatory Bowel Diseases.png
- 37 Autoimmune diseases.png
6Vitamin E
16Vitamin K
- 1 Immunomodulation.png
- 2 Cognition.png
- 3 Crohn's Disease.png
- 4 Crohn's Disease.png
- 5 Anti-inflammatory.png
- 6 Anti-inflammatory.png
- 7 Inflammatory Bowel Disease.png
- 8 Inflammatory Bowel Disease.png
- 9 Inflammatory Bowel Disease.png
- 10 Inflammatory Bowel Diseases.png
- 11 Inflammatory Bowel Diseases.png
- 12 Inflammatory Bowel Disease.png
- 2001.12 - C. Vitamin K administration to elderly patients withosteoporosis induces no hemostatic activation, even in those with suspected vitamin K deficiency.pdf
- 2011.09 - A. Safety and toxicological evaluation of a synthetic vitamin K2, menaquinone-7.pdf
- 2017.06 - D. Vitamins K1 and K2 - The Emerging Group of Vitamins Required for Human Health.pdf
- 2017.07 - B. US Pharmacopeial Convention safety evaluation of menaquinone-7, a form of vitamin K.pdf
22Zinc
- 1 thyroid.png
- 4 fatigue.png
- 5 lethargy.png
- 7 thyroid.png
- 8 thyroid hormone receptor.png
- 9 hair loss.png
- 10 hair loss.png
- 11 hair loss.png
- 12 hair loss IDEM11.png
- 13 inflammatory bowel disease.png
- 14 inflammatory bowel disease
- 15 inflammatory bowel disease.png
- 16 IBD
- 17 intestinal barrier function.png
- 18 intestinal barrier function.png
- 19 intestinal barrier function.png
- 25 Crohn's disease.png
- 26 Crohn's disease.png
- 27 Crohn's disease.png
- 28 Crohn's disease.png
- 29 Inflammatory bowel Diseases.png
- 30 Inflammatory bowel Diseases.png
